Eurofins Scientific SE (Paris: ERF) repurchased a total of 110,000 of its own shares between July 27 and July 31, 2026, according to a regulatory disclosure.

The transactions were carried out across two venues: Euronext Paris (XPAR) and the Cboe Europe exchange (CEUX). The weighted average purchase price across all transactions was €67.9286 per share.

Daily transaction details are as follows:

On July 27, the company bought 5,000 shares at a weighted average price of €67.0235 on CEUX and 20,000 shares at €67.0505 on XPAR. On July 28, it purchased 5,000 shares at €67.6794 on CEUX and 20,000 shares at €67.5190 on XPAR. On July 29, purchases totaled 15,000 shares at €67.9674 on XPAR and 5,000 shares at €68.0623 on CEUX. On July 30, the company bought 15,000 shares at €68.6993 on XPAR and 5,000 shares at €68.6458 on CEUX. On July 31, it acquired 15,000 shares at €68.6831 on XPAR and 5,000 shares at €68.6912 on CEUX.

The buyback was conducted in accordance with Article 5(1)(b) of EU Market Abuse Regulation No. 596/2014.